New Patented Medicines Reported to PMPRB

Up to date as of August 10, 2018

Search by:

Keyword:

Status:

Year Reported*:

* Note: Drugs with Price Review Records linked from the brand name are only available from 2010 onward (records for 2011 will be populated over the next few months). Summary Reports are available for drug products reported prior to 2010.

Year	Company	Brand Name	Chemical Name	DIN	Therapeutic Use	Date of First Sale	Status
2016	Abbvie	Synagis - 100 mg/vial	palivizumab	02438364	Respiratory Syncytial Virus	7 Nov 2016	Within Guidelines
2016	Abbvie	Synagis - 50 mg/vial	palivizumab	02438372	Respiratory Syncytial Virus	3 Nov 2016	Within Guidelines
2016	Abbvie	Venclexta - 10 mg/tablet	venetoclax	02458039	Cancer	31 Oct 2016	Within Guidelines
2016	Abbvie	Venclexta - 50 mg/tablet	venetoclax	02458047	Cancer	31 Oct 2016	Within Guidelines
2016	Abbvie	Venclexta - 100 mg/tablet	venetoclax	02458055	Cancer	2 Nov 2016	Within Guidelines
2016	Abbvie	Venclexta 10/50/100 - 1 N.A./kit	venetoclax	02458063	Cancer	31 Oct 2016	Within Guidelines
2016	Abbvie	Humira - 40 mg/syringe	adalimumab	02458349	Rheumatoid Arthritis	16 Nov 2016	VCU
2016	Abbvie	Humira - 40 mg/pen	adalimumab	02458357	Rheumatoid Arthritis	16 Nov 2016	VCU
2016	Acerus Pharmaceuticals SRL	Natesto - 5.5 mg/actuation	testosterone nasal gel	02450550	Hypogonadism	6 May 2016	Within Guidelines
2016	Actelion Pharmaceuticals Canada Inc.	Uptravi - 200 mg/tablet	selexipag	02451158	Hypertension	21 Apr 2016	Within Guidelines
2016	Actelion Pharmaceuticals Canada Inc.	Uptravi - 400 mg/tablet	selexipag	02451166	Hypertension	21 Apr 2016	Within Guidelines
2016	Actelion Pharmaceuticals Canada Inc.	Uptravi - 600 mg/tablet	selexipag	02451174	Hypertension	21 Apr 2016	Within Guidelines
2016	Actelion Pharmaceuticals Canada Inc.	Uptravi - 800 mg/tablet	selexipag	02451182	Hypertension	21 Apr 2016	Within Guidelines
2016	Actelion Pharmaceuticals Canada Inc.	Uptravi - 1000 mg/tablet	selexipag	02451190	Hypertension	21 Apr 2016	Within Guidelines
2016	Actelion Pharmaceuticals Canada Inc.	Uptravi - 1200 mg/tablet	selexipag	02451204	Hypertension	21 Apr 2016	Within Guidelines
2016	Actelion Pharmaceuticals Canada Inc.	Uptravi - 1400 mg/tablet	selexipag	02451212	Hypertension	21 Apr 2016	Within Guidelines
2016	Actelion Pharmaceuticals Canada Inc.	Uptravi - 1600 mg/tablet	selexipag	02451220	Hypertension	21 Apr 2016	Within Guidelines
2016	Alexion Pharmaceuticals Inc.	Strensiq - 18 mg/vial	asfotase alfa	02444615	Paediatric-onset Hypophosphatasia	20 Oct 2015 (Patented 21 Jun 2016)	Subject to Investigation
2016	Alexion Pharmaceuticals Inc.	Strensiq - 80 mg/vial	asfotase alfa	02444658	Paediatric-onset Hypophosphatasia	17 Feb 2016	Subject to Investigation
2016	Allergan Inc.	Fetzima - 80 mg/capsule	levomilnacipran	02440997	Antidepressant	22 Apr 2016	Within Guidelines
2016	Allergan Inc.	Fetzima - 120 mg/capsule	levomilnacipran	02441004	Antidepressant	22 Apr 2016	Within Guidelines
2016	Allergan Inc.	Belkyra - 10 mg/mL	deoxycholic acid	02443910	Submental Fat	26 Jan 2016	Within Guidelines
2016	Amgen Canada Inc.	Neupogen - 0.6 mg/mL	filgrastim	02420104	Cancer	28 Jan 2016	Does Not Trigger Investigation
2016	Amgen Canada Inc.	Neupogen - 0.6 mg/mL	filgrastim	02420112	Cancer	2 Feb 2016	Within Guidelines
2016	Amgen Canada Inc.	Blincyto - 38.5 mcg/vial	blinatumomab	02450283	Cancer	17 Mar 2016	Within Guidelines
2016	Amgen Canada Inc.	Kyprolis - 60 mg/vial	carfilzomin	02451034	Cancer	11 Feb 2016	Within Guidelines
2016	AstraZeneca Canada Inc.	Bydureon - 2 mg/dose	exenatide	02448610	Diabetes	16 Feb 2016	Within Guidelines
2016	AstraZeneca Canada Inc.	Xigduo 5/1000 - 1005 mg/tablet	dapagliflozin / metformin hydrochloride	02449943	Diabetes	8 Feb 2016	Within Guidelines
2016	AstraZeneca Canada Inc.	Lynparza - 50 mg/capsule	olaparib	02454408	Cancer	16 May 2016	Subject to Investigation
2016	AstraZeneca Canada Inc.	Xigduo 5/850 - 855 mg/tablet	dapagliflozin / metformin hydrochloride	02449935	Diabetes	9 Feb 2016	Within Guidelines
2016	AstraZeneca Canada Inc.	Brilinta - 60 mg/tablet	ticagrelor	02455005	Atherothrombosis	13 Jun 2016	Within Guidelines
2016	AstraZeneca Canada Inc.	Tagrisso - 40 mg/tablet	osimertinib	02456214	Cancer	19 Jul 2016	Within Guidelines
2016	AstraZeneca Canada Inc.	Tagrisso - 80 mg/tablet	osimertinib	02456222	Cancer	19 Jul 2016	Within Guidelines
2016	Bayer Inc.	Kovaltry	antihemophilic factor (recombinant)	02451441	Hemophilia	16 Jun 2016	Within Guidelines
2016	Bayer Inc.	Kovaltry	antihemophilic factor (recombinant)	02451468	Hemophilia	16 Jun 2016	Within Guidelines
2016	Bayer Inc.	Kovaltry	antihemophilic factor (recombinant)	02451476	Hemophilia	16 Jun 2016	Within Guidelines
2016	Bayer Inc.	Kovaltry	antihemophilic factor (recombinant)	02451484	Hemophilia	16 Jun 2016	Within Guidelines
2016	Bayer Inc.	Kovaltry	antihemophilic factor (recombinant)	02451492	Hemophilia	16 Jun 2016	Within Guidelines
2016	Bioverativ Canada Inc.	Alprolix - 500 IU/vial	coagulatoin factor IX (recombinant)	02422913	Hemophilia	15 Dec 2015 (Patented 9 Aug 2016)	Within Guidelines
2016	Bioverativ Canada Inc.	Alprolix - 1000 IU/vial	coagulatoin factor IX (recombinant)	02422921	Hemophilia	20 Jan 2016 (Patented 9 Aug 2016)	Within Guidelines
2016	Bioverativ Canada Inc.	Alprolix - 2000 IU/vial	coagulatoin factor IX (recombinant)	02422948	Hemophilia	15 Dec 2015 (Patented 9 Aug 2016)	Within Guidelines
2016	Bioverativ Canada Inc.	Alprolix - 3000 IU/vial	coagulatoin factor IX (recombinant)	02422956	Hemophilia	20 Dec 2015 (Patented 9 Aug 2016)	Within Guidelines
2016	Bioverativ Canada Inc.	Eloctate - 3000 IU/vial	Antihemophilic factor (Recombinant, B-domain deleted)	02430355	Hemophilia	20 Jan 2016 (Patented 9 Aug 2016)	Within Guidelines
2016	Bioverativ Canada Inc.	Eloctate - 2000 IU/vial	Antihemophilic factor (Recombinant, B-domain deleted)	02430347	Hemophilia	20 Jan 2016 (Patented 9 Aug 2016)	Within Guidelines
2016	Bioverativ Canada Inc.	Eloctate - 1500 IU/vial	Antihemophilic factor (Recombinant, B-domain deleted)	02430339	Hemophilia	20 Jan 2016 (Patented 9 Aug 2016)	Within Guidelines
2016	Bioverativ Canada Inc.	Eloctate - 1000 IU/vial	Antihemophilic factor (Recombinant, B-domain deleted)	02430320	Hemophilia	20 Jan 2016 (Patented 9 Aug 2016)	Within Guidelines
2016	Bioverativ Canada Inc.	Eloctate - 750 IU/vial	Antihemophilic factor (Recombinant, B-domain deleted)	02430312	Hemophilia	20 Jan 2016 (Patented 9 Aug 2016)	Within Guidelines
2016	Bioverativ Canada Inc.	Eloctate - 500 IU/vial	Antihemophilic factor (Recombinant, B-domain deleted)	02430304	Hemophilia	20 Jan 2016 (Patented 9 Aug 2016)	Within Guidelines
2016	Bioverativ Canada Inc.	Eloctate - 250 IU/vial	Antihemophilic factor (Recombinant, B-domain deleted)	02430290	Hemophilia	20 Jan 2016 (Patented 9 Aug 2016)	Within Guidelines
2016	Boehringer Ingelheim (Canada) Ltd.	Synjardy 12.5/1000 - 1012.5 mg/tablet	empagliflozin/meformin hydrochloride	02456621	Diabetes	3 Aug 2016	Within Guidelines
2016	Boehringer Ingelheim (Canada) Ltd.	Synjardy 12.5/500 - 512.5 mg/tablet	empagliflozin/meformin hydrochloride	02456605	Diabetes	3 Aug 2016	Within Guidelines
2016	Boehringer Ingelheim (Canada) Ltd.	Synjardy 12.5/850 - 862.5 mg/tablet	empagliflozin/meformin hydrochloride	02456613	Diabetes	3 Aug 2016	Within Guidelines
2016	Boehringer Ingelheim (Canada) Ltd.	Synjardy 5/1000 - 1005 mg/tablet	empagliflozin/meformin hydrochloride	02456591	Diabetes	3 Aug 2016	Within Guidelines
2016	Boehringer Ingelheim (Canada) Ltd.	Synjardy 5/500 - 505 mg/tablet	empagliflozin/meformin hydrochloride	02456575	Diabetes	3 Aug 2016	Within Guidelines
2016	Boehringer Ingelheim (Canada) Ltd.	Synjardy 5/850 - 855 mg/tablet	empagliflozin/meformin hydrochloride	02456583	Diabetes	3 Aug 2016	Within Guidelines
2016	Bristol-Myers Squibb Canada Co.	Sunvepra - 100 mg/capsule	asunaprevir	02452294	Hepatitis C	22 Apr 2016	Within Guidelines
2016	Bristol-Myers Squibb Canada Co.	Evotaz - 450 mg/tablet	atazanavir sulphate/ cobicistat	02446731	HIV	11 Feb 2016	Within Guidelines
2016	Cipher Pharmaceuticals Inc.	Beteflam - 2.25 mg/patch	betamethasone valerate	02449773	Psoriasis	6 Apr 2016	Within Guidelines
2016	Duchesnay Inc.	Pregvit	multivitamins and minerals	02451573	Dietary Supplement	6 Jul 2016	Within Guidelines
2016	Duchesnay Inc.	Pregvit Folic 5	multivitamins and minerals	02451581	Dietary Supplement	31 Aug 2016	Within Guidelines
2016	Eisai Limited	Lenvima - 10 mg/day	lenvatinib mesylate	02450321	Cancer	29 Jul 2016	Within Guidelines
2016	Eisai Limited	Lenvima 10/10 - 20 mg/day	lenvatinib mesylate	02450305	Cancer	13 Apr 2016	Within Guidelines
2016	Eisai Limited	Lenvima 10/10/4 - 24 mg/day	lenvatinib mesylate	02450291	Cancer	13 Apr 2016	Within Guidelines
2016	Eisai Limited	Lenvima 10/4 - 14 mg/day	lenvatinib mesylate	02450313	Cancer	13 Apr 2016	Within Guidelines
2016	Eli Lilly Canada Inc.	Trulicity - 0.75 mg/pen	dulaglutide	02448599	Diabetes	8 Jan 2016	Within Guidelines
2016	Eli Lilly Canada Inc.	Taltz - 80 mg/mL	ixekizumab	02455102	Psoriasis	11 Aug 2016	Within Guidelines
2016	Eli Lilly Canada Inc.	Taltz - 80 mg/mL	ixekizumab	02455110	Psoriasis	11 Aug 2016	Within Guidelines
2016	Ferring Inc.	Cortiment - 9 mg/tablet	budesonide	02455889	Ulcerative colitis	25 Jul 2016	Within Guidelines
2016	Galderma Canada Inc.	TactuPump Forte - 70 g/pump	adapalene/ benzoyl peroxide	02446235	Acne	4 Jan 2016	Within Guidelines
2016	Gilead Sciences Inc.	Genvoya 200/150/150/10 - 510 mg/tablet	elvitegravir / cobicistat / emtricitabine / tefofovir alafenamide	02449498	HIV	3 Feb 2016	VCU
2016	Gilead Sciences Inc.	Epclusa 400/100 - 500 mg/tablet	sofosbuvir/velpatasvir	02456370	Hepatitis C	2 Aug 2016	Within Guidelines
2016	Gilead Sciences Inc.	Descovy 200/10 - 210 mg/tablet	emtricitabine/tenofovir alafenamide	02454416	HIV	3 Jun 2016	Within Guidelines
2016	Gilead Sciences Inc.	Descovy 200/25 - 225 mg/tablet	emtricitabine/tenofovir alafenamide	02454424	HIV	3 Jun 2016	Within Guidelines
2016	GlaxoSmithKline Inc.	Menjugate Liquid	meningococcal group C conjugate vaccine	02440709	Vaccine	7 Oct 2015 (Patented 16 Aug 2016)	Within Guidelines
2016	GlaxoSmithKline Inc.	Arnuity Ellipta - 100 mcg/dose	fluticasone furoate	02446561	Asthma	26 Jan 2016	Within Guidelines
2016	GlaxoSmithKline Inc.	Arnuity Ellipta - 200 mcg/dose	fluticasone furoate	02446588	Asthma	14 Dec 2015	Within Guidelines
2016	Hoffman-La Roche Limited	Cotellic - 20 mg/tablet + Zelboraf – 240 mg/tablet	cobimetinib	02452340	Cancer	6 Apr 2016	Within Guidelines
2016	Hoffman-La Roche Limited	Rituxan SC - 120 mg/mL	rituximab	02457350	Cancer	22 Nov 2016	Within Guidelines
2016	Hospira Healthcare Corporation (Canada)	Precedex - 4 mcg/mL	dexmedetomidine hydrochloride	02437147	Sedation	9 May 2016	Within Guidelines
2016	Janssen Inc.	Zytiga - 500 mg/tablet	abiraterone acetate	02457113	Cancer	13 Oct 2016	Does Not Trigger Investigation
2016	Janssen Inc.	Invega Trinza - 175 mg/syringe	paliperidone palmitate	02455943	Schizophrenia	2 Aug 2016	Within Guidelines
2016	Janssen Inc.	Invega Trinza - 263 mg/syringe	paliperidone palmitate	02455986	Schizophrenia	2 Aug 2016	Within Guidelines
2016	Janssen Inc.	Invega Trinza - 350 mg/syringe	paliperidone palmitate	02455994	Schizophrenia	2 Aug 2016	Within Guidelines
2016	Janssen Inc.	Invega Trinza - 525 mg/syringe	paliperidone palmitate	02456001	Schizophrenia	2 Aug 2016	Within Guidelines
2016	Janssen Inc.	Invokamet 150/1000 - 1150 mg/tablet	canagliflozin/metformin hydrochloride	02455455	Diabetes	13 Jul 2016	Within Guidelines
2016	Janssen Inc.	Invokamet 150/500 - 650 mg/tablet	canagliflozin/metformin hydrochloride	02455439	Diabetes	13 Jul 2016	Within Guidelines
2016	Janssen Inc.	Invokamet 150/850 - 1000 mg/tablet	canagliflozin/metformin hydrochloride	02455447	Diabetes	13 Jul 2016	Within Guidelines
2016	Janssen Inc.	Invokamet 50/1000 - 1050 mg/tablet	canagliflozin/metformin hydrochloride	02455420	Diabetes	13 Jul 2016	Within Guidelines
2016	Janssen Inc.	Invokamet 50/500 - 550 mg/tablet	canagliflozin/metformin hydrochloride	02455404	Diabetes	13 Jul 2016	Within Guidelines
2016	Janssen Inc.	Invokamet 50/850 - 900 mg/tablet	canagliflozin/metformin hydrochloride	02455412	Diabetes	13 Jul 2016	Within Guidelines
2016	Leo Pharma Inc.	Enstilar - 1 N.A./dose	calcipotriol/betamethasone	02457393	Psoriasis	11 Nov 2016	Within Guidelines
2016	Merck Canada Inc.	Zerbaxa 1000/500 - 1500 mg/vial	ceftolozane / tazobactam	02446901	Antibiotic	12 Jan 2016	Within Guidelines
2016	Merck Canada Inc.	Brenzys - 50 mg/mL	etanercept	02455331	Rheumatoid arthritis	23 Sep 2016	Within Guidelines
2016	Merck Canada Inc.	Brenzys - 50 mg/mL	etanercept	02455323	Rheumatoid arthritis	23 Sep 2016	Within Guidelines
2016	Merck Canada Inc.	Zepatier 50/100 - 150 mg/tablet	elbasvir / grazoprevir	02451131	Hepatitis C	25 Jan 2016	VCU
2016	Merck Canada Inc.	Bridion - 100 mg/mL	sugammadex	02451816	Selective Relaxant Binding Agent	19 Feb 2016	VCU
2016	Novartis Pharma Canada Inc.	Afinitor - 7.5 mg/tablet	everolimus	02450267	Cancer	05 Apr 2016	Does Not Trigger Investigation
2016	Novartis Pharma Canada Inc.	Signifor LAR - 20 mg/vial	pasireotide	02437252	Acromegaly	28 Jan 2016	Within Guidelines
2016	Novartis Pharma Canada Inc.	Jadenu - 90 mg/tablet	deferasirox	02452219	Chronic iron overload	24 Mar 2016	Within Guidelines
2016	Novartis Pharma Canada Inc.	Jadenu - 180 mg/tablet	deferasirox	02452227	Chronic iron overload	24 Mar 2016	Within Guidelines
2016	Novartis Pharma Canada Inc.	Jadenu - 360 mg/tablet	deferasirox	02452235	Chronic iron overload	24 Mar 2016	Within Guidelines
2016	Octapharma Canada Inc.	Nuwiq - 250 unit/vial	Antihemophilic factor (Recombinant, B-domain deleted), Antihemorrhagic Blood Coagulation Factor VIII	02432951	Hemophilia	22 Dec 2015	Within Guidelines
2016	Octapharma Canada Inc.	Nuwiq - 500 unit/vial	Antihemophilic factor (Recombinant, B-domain deleted), Antihemorrhagic Blood Coagulation Factor VIII	02432978	Hemophilia	22 Dec 2015	Within Guidelines
2016	Octapharma Canada Inc.	Nuwiq - 2000 IU/Vial	Antihemophilic factor (Recombinant, B-domain deleted), Antihemorrhagic Blood Coagulation Factor VIII	02432994	Hemophilia	14 Jul 2016	Within Guidelines
2016	Octapharma Canada Inc.	Nuwiq - 1000 IU/Vial	Antihemophilic factor (Recombinant, B-domain deleted), Antihemorrhagic Blood Coagulation Factor VIII	02432986	Hemophilia	21 Jul 2016	Within Guidelines
2016	Paladin Labs Inc.	Iclusig - 45 mg/tablet	ponatinib	02437341	Cancer	7 Jan 2016	Within Guidelines
2016	Pendopharm, Division of Pharmascience Inc.	Vibativ - 750 mg/vial	telavancin hydrochloride	02330725	Antibiotic	6 Jan 2016	Within Guidelines
2016	Pfizer Canada Inc.	Somavert - 25 mg/vial	pegvisomant	02448831	Acromegaly	10 Mar 2016	Within Guidelines
2016	Pfizer Canada Inc.	Somavert - 30 mg/vial	pegvisomant	02448858	Acromegaly	10 Mar 2016	Within Guidelines
2016	Pfizer Canada Inc.	Ibrance - 75 mg/capsule	palbociclib	02453150	Cancer	20 Apr 2016	Within Guidelines
2016	Pfizer Canada Inc.	Ibrance - 100 mg/capsule	palbociclib	02453169	Cancer	19 Apr 2016	Within Guidelines
2016	Pfizer Canada Inc.	Ibrance - 125 mg/capsule	palbociclib	02453177	Cancer	19 Apr 2016	Within Guidelines
2016	PTC Therapeutics International Limited	Translarna - 1,000 mg/pouch	ataluren		Duchenne muscular dystrophy	8 Feb 2016	Within Guidelines
2016	Purdue Pharma	BuTrans - 15 mg/patch	buprenorphine	02450771	Pain	15 Jun 2016	Does Not Trigger Investigation
2016	Servier Canada Inc.	Viacoram 3.5/2.5 - 6 mg/tablet	perindopril arginine/amlodipine	02451530	Hypertension	05 Apr 2016	Within Guidelines
2016	Servier Canada Inc.	Viacoram 7/5 - 12 mg/tablet	perindopril arginine/amlodipine	02451557	Hypertension	05 Apr 2016	Within Guidelines
2016	Servier Canada Inc.	Viacoram 14/10 - 24 mg/tablet	perindopril arginine/amlodipine	02451549	Hypertension	05 Apr 2016	Within Guidelines
2016	Takeda Canada Inc.	Ninlaro - 2.3 mg/capsule	ixazomib citrate	02456796	Cancer	21 Sep 2016	Within Guidelines
2016	Takeda Canada Inc.	Ninlaro - 3 mg/capsule	ixazomib citrate	02456818	Cancer	21 Sep 2016	Within Guidelines
2016	Takeda Canada Inc.	Ninlaro - 4 mg/capsule	ixazomib citrate	02456826	Cancer	21 Sep 2016	Within Guidelines
2016	Teva Canada Innovation G.P.-S.E.N.C	Copaxone - 40 mg/mL	glatiramer acetate	02456915	Mutiple Sclerosis	26 Aug 2016	Does Not Trigger Investigation
2016	UCB Canada Inc.	Brivlera - 10 mg/tablet	brivaracetam	02452936	Epilepsy	2 May 2016	Within Guidelines
2016	UCB Canada Inc.	Brivlera - 25 mg/tablet	brivaracetam	02452944	Epilepsy	2 May 2016	Within Guidelines
2016	UCB Canada Inc.	Brivlera - 50 mg/tablet	brivaracetam	02452952	Epilepsy	2 May 2016	Within Guidelines
2016	UCB Canada Inc.	Brivlera - 75 mg/tablet	brivaracetam	02452960	Epilepsy	2 May 2016	Within Guidelines
2016	UCB Canada Inc.	Brivlera - 100 mg/tablet	brivaracetam	02452979	Epilepsy	2 May 2016	Within Guidelines
2016	Vertex Pharmaceuticals Canada Inc.	Orkambi 200/125 - 325 mg/tablet	lumacaftor / ivacaftor	02451379	Cystic Fibrosis	27 Jan 2016	Does Not Trigger Investigation
2016	ViiV Healthcare Ulc	Tivicay - 50 mg/tablet	dolutegravir	02414945	HIV	8 Nov 2013 (Patented 26 Apr 2016)	Within Guidelines

Language selection

Search and menus

Search

New Patented Medicines Reported to PMPRB

Search by: